These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22529965)

  • 1. Regulation of chemokine and chemokine receptor expression by PPARγ in adipocytes and macrophages.
    Nguyen MT; Chen A; Lu WJ; Fan W; Li PP; Oh DY; Patsouris D
    PLoS One; 2012; 7(4):e34976. PubMed ID: 22529965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin A modulates thiazolidinedione-mediated suppression of tumor necrosis factor α-induced lipolysis in 3T3-L1 adipocytes.
    Lu JC; Chang YT; Wang CT; Lin YC; Lin CK; Wu ZS
    PLoS One; 2013; 8(8):e71517. PubMed ID: 23951179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARgamma activation in adipocytes is sufficient for systemic insulin sensitization.
    Sugii S; Olson P; Sears DD; Saberi M; Atkins AR; Barish GD; Hong SH; Castro GL; Yin YQ; Nelson MC; Hsiao G; Greaves DR; Downes M; Yu RT; Olefsky JM; Evans RM
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22504-9. PubMed ID: 20018750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.
    Guo X; Li H; Xu H; Halim V; Thomas LN; Woo SL; Huo Y; Chen YE; Sturino JM; Wu C
    J Nutr Biochem; 2013 May; 24(5):770-5. PubMed ID: 22841546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M; Geeraert B; Arnould T; Tsatsanis C; Holvoet P
    PLoS One; 2013; 8(4):e62253. PubMed ID: 23620818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).
    Jeninga EH; Bugge A; Nielsen R; Kersten S; Hamers N; Dani C; Wabitsch M; Berger R; Stunnenberg HG; Mandrup S; Kalkhoven E
    J Biol Chem; 2009 Sep; 284(39):26385-93. PubMed ID: 19633298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling.
    Roh HC; Kumari M; Taleb S; Tenen D; Jacobs C; Lyubetskaya A; Tsai LT; Rosen ED
    Mol Metab; 2020 Dec; 42():101086. PubMed ID: 32992037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice.
    Stromsdorfer KL; Yamaguchi S; Yoon MJ; Moseley AC; Franczyk MP; Kelly SC; Qi N; Imai S; Yoshino J
    Cell Rep; 2016 Aug; 16(7):1851-60. PubMed ID: 27498863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice.
    Foryst-Ludwig A; Hartge M; Clemenz M; Sprang C; Hess K; Marx N; Unger T; Kintscher U
    Cardiovasc Diabetol; 2010 Oct; 9():64. PubMed ID: 20955583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged induction activates Cebpα independent adipogenesis in NIH/3T3 cells.
    Shao HY; Hsu HY; Wu KS; Hee SW; Chuang LM; Yeh JI
    PLoS One; 2013; 8(1):e51459. PubMed ID: 23326314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
    Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells.
    Crossno JT; Majka SM; Grazia T; Gill RG; Klemm DJ
    J Clin Invest; 2006 Dec; 116(12):3220-8. PubMed ID: 17143331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure.
    Jin D; Guo H; Bu SY; Zhang Y; Hannaford J; Mashek DG; Chen X
    FASEB J; 2011 Feb; 25(2):754-64. PubMed ID: 20974668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes.
    Milton FA; Cvoro A; Amato AA; Sieglaff DH; Filgueira CS; Arumanayagam AS; de Lima Mdo C; Pitta IR; de Assis Rocha Neves F; Webb P
    Biochem Biophys Res Commun; 2015 Aug; 464(3):718-23. PubMed ID: 26168725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation.
    Haas B; Hass MDS; Voltz A; Vogel M; Walther J; Biswas A; Hass D; Pfeifer A
    Mol Metab; 2024 Jul; 85():101956. PubMed ID: 38735390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.